What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor?
Year: 2025
Type: article
Language: en
Topic: Psoriasis: Treatment and Pathogenesis
Authors and affiliations:
raw_author_name: Yizhang Liu
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China
raw_author_name: Kun Hu
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
Furong Laboratory, Changsha, China
raw_author_name: Yongfang Duan
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
raw_author_name: Junchen Chen
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
Furong Laboratory, Changsha, China
raw_author_name: Panpan Liu
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China
raw_author_name: Shuangyuan Zhou
raw_affiliation_strings: Department of Radiology, Xiangya Hospital, Central South University
National Clinical Research Centre for Geriatric Disorders, Xiangya Hospital, Central South University
Department of Radiology, Xiangya Hospital, Central South University, Changsha, China
raw_author_name: Mi Zhang
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
Furong Laboratory, Changsha, China
raw_author_name: Yehong Kuang
raw_affiliation_strings: Furong Laboratory
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital
Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology
The Department of Dermatology, Xiangya Hospital, Central South University
Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China
The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China